{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:45:45Z","timestamp":1762253145635},"reference-count":28,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,4]]},"abstract":"<jats:p>Historically, the human prevalence of <jats:italic>Wuchereria bancrofti<\/jats:italic> infection in Wallis and Futuna (WAF) was among the highest in the Pacific and mass drug administration (MDA) against lymphatic filariasis (LF) either with diethylcarbamazine citrate (DEC) or the combination of DEC and albendazole had been implemented for decades. To determine whether LF antigen prevalence in WAF was lower than 1%, the infection threshold for elimination in an area where <jats:italic>Aedes<\/jats:italic> spp. are the principal vectors, we conducted the WHO-recommended transmission assessment survey in 2012. We present the results of a school-based survey, which targeted 1,014 students in all 13 elementary schools in WAF. From a fingerprick, the circulating filarial antigen (CFA) positivity was checked for grade 2\u20135 students using BinaxNOW filariasis test (immunochromatographic test). Of 935 children tested, three were positive for CFA in two schools. At the territory level, this was below the critical cutoff of nine cases, if the whole territory was considered as a single evaluation unit. The prevalence of CFA in WAF is less than 1%, reaching the goal for LF elimination set by the WHO. We were able to recommend stopping LF MDA and move to post-MDA surveillance to detect any recrudescence. This survey successfully paved the way for WAF to be validated as achieving LF elimination as a public health problem by 2020.<\/jats:p>","DOI":"10.4269\/ajtmh.19-0476","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T07:00:45Z","timestamp":1570518045000},"page":"1325-1330","source":"Crossref","is-referenced-by-count":8,"title":["An Expanded Transmission Assessment Survey to Confirm the Interruption of Lymphatic Filariasis Transmission in Wallis and Futuna"],"prefix":"10.4269","volume":"101","author":[{"given":"Lorenzo","family":"Pezzoli","sequence":"first","affiliation":[{"name":"Epidemiology Consultant, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hye","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pacific Technical Support, World Health Organization, Suva, Fiji;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Pierre","family":"Mathelin","sequence":"additional","affiliation":[{"name":"Public Health Agency, Mata Utu, Wallis and Futuna;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Hennessey","sequence":"additional","affiliation":[{"name":"Western Pacific Regional Office, World Health Organization, Manila, The Philippines"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padmasiri","family":"Eswara Aratchige","sequence":"additional","affiliation":[{"name":"Division of Pacific Technical Support, World Health Organization, Suva, Fiji;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayaprakash","family":"Valiakolleri","sequence":"additional","affiliation":[{"name":"Division of Pacific Technical Support, World Health Organization, Suva, Fiji;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Trop Med Int Health","first-page":"591","article-title":"The global programme to eliminate lymphatic filariasis","volume":"5","author":"Ottesen","year":"2000"},{"key":"b2","series-title":"Trends Parasitol","first-page":"109","article-title":"The PacELF programme: will mass drug administration be enough?","volume":"18","author":"Burkot","year":"2002"},{"year":"2017","series-title":"Global Progress Towards Elimination","author":"WHO","key":"b3"},{"key":"b4","series-title":"Parasit Vectors","first-page":"2","article-title":"Mathematical models for lymphatic filariasis transmission and control: challenges and prospects","volume":"1","author":"Swaminathan","year":"2008"},{"key":"b5","series-title":"Adv Parasitol","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","article-title":"Lymphatic filariasis: treatment, control and elimination","volume":"61","author":"Ottesen","year":"2006"},{"key":"b6","series-title":"Lancet Infect Dis","first-page":"223","article-title":"Mathematical modelling and the control of lymphatic filariasis","volume":"4","author":"Michael","year":"2004"},{"year":"2011","series-title":"Lymphatic Filariasis: Monitoring and Epidemiological Assessment of Mass Drug Administration","author":"WHO","key":"b7"},{"key":"b8","series-title":"Trop Med Int Health","first-page":"1756","article-title":"Comparing two survey methods of measuring health-related indicators: lot quality assurance sampling and demographic health surveys","volume":"20","author":"Anoke","year":"2015"},{"year":"2006","series-title":"The PacELF Way: Towards the Elimination of Lymphatic Filariasis from the Pacific, 1999\u20132005","author":"WHO WPRO","key":"b9"},{"year":"2017","series-title":"PCT Databank","author":"WHO","key":"b10"},{"year":"2008","series-title":"Wallis et Futuna","author":"National Institute of Statistics and Economy, France","key":"b11"},{"year":"2014","series-title":"Programme de Wallis et Futuna","author":"Secretariat of Pacific Community","key":"b12"},{"key":"b13","series-title":"Trop Med Health","first-page":"8","article-title":"Impact of the lymphatic filariasis control program towards elimination of filariasis in Vanuatu, 1997\u20132006","volume":"45","author":"Allen","year":"2017"},{"year":"1959","series-title":"Enqu\u00eate Sur la Filariose \u00e0 Wallis","author":"Rageau","key":"b14"},{"key":"b15","series-title":"Med Trop (Mars)","first-page":"665","article-title":"Wuchereria bancrofti human aperiodic filariasis in French territory of Wallis and Futuna [article in French]","volume":"41","author":"Fauran","year":"1981"},{"key":"b16","series-title":"M\u00e9d Mal Infect","first-page":"217","article-title":"Distribution g\u00e9ographique actuelle de la filariose lymphathique. 7\u2013Pacifique Sud","volume":"7","author":"Rodhain","year":"1977"},{"year":"2018","series-title":"Transmission Assessment Survey (TAS)","author":"GAELF","key":"b17"},{"key":"b18","series-title":"Am J Trop Med Hyg","first-page":"272","article-title":"Evidence for stopping mass drug administration for lymphatic filariasis in some, but not all local government areas of Plateau and Nasarawa states, Nigeria","volume":"87","author":"King","year":"2012"},{"year":"1999","series-title":"Framework for Program Evaluation in Public Health","author":"Milstein","key":"b19"},{"key":"b20","series-title":"PLoS Negl Trop Dis","first-page":"e0007365","article-title":"Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka","volume":"13","author":"Rao","year":"2019"},{"key":"b21","series-title":"Malar J","first-page":"170","article-title":"Outdoor biting by Anopheles mosquitoes on Bioko Island does not currently impact on malaria control","volume":"14","author":"Bradley","year":"2015"},{"key":"b22","series-title":"Am J Trop Med Hyg","first-page":"333","article-title":"Parasite antigenemia without microfilaremia in bancroftian filariasis","volume":"55","author":"Weil","year":"1996"},{"key":"b23","series-title":"Am J Trop Med Hyg","first-page":"550","article-title":"Bancroftian filariasis infection, disease, and specific antibody response patterns in a high and a low endemicity community in east Africa","volume":"66","author":"Simonsen","year":"2002"},{"year":"2017","series-title":"NTD Newsletter Issue 6","author":"NTD News","key":"b24"},{"year":"2017","series-title":"Validation of Elimination of Lymphatic Filariasis as a Public Health Problem","author":"WHO","key":"b25"},{"year":"2018","series-title":"WHO Validates 3 More Countries for Eliminating Lymphatic Filariasis","author":"WHO","key":"b26"},{"year":"2012","series-title":"Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap For Implementation","author":"WHO","key":"b27"},{"key":"b28","series-title":"Rev Inst Med Trop Sao Paulo","first-page":"125","article-title":"Field evaluation of the whole blood immunochromatographic test for rapid bancroftian filariasis diagnosis in the northeast of Brazil","volume":"45","author":"Braga","year":"2003"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/101\/6\/article-p1325.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/101\/6\/article-p1325.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/101\/6\/article-p1325.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T21:41:59Z","timestamp":1722462119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/101\/6\/article-p1325.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":28,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.19-0476","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"type":"print","value":"0002-9637"},{"type":"electronic","value":"1476-1645"}],"subject":[],"published":{"date-parts":[[2019,12,4]]}}}